.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent research highlights a significant breakthrough regarding the PBX1 variant 46,XY DSD connection. The pre-B cell leukemia transcription factor (PBX1) is vital during human embryonic development. Mutations in this gene often lead to complex clinical presentations. In this specific case, researchers identified a novel missense variant, c.710G>C (p.R237T), in a Taiwanese girl with 46,XY Differences of Sex Development (DSD). Consequently, this finding provides new insights into the genetic landscape of gonadal dysgenesis and sexual development.
The study utilized functional validation to assess the impact of the p.R237T variant. Compared to wild-type PBX1, the mutated protein exhibited significantly reduced stability. Furthermore, the variant hampered nuclear translocation within HEK293 cells. This disruption is critical because PBX1 must enter the nucleus to regulate gene expression properly. Additionally, RNA sequencing revealed alterations in several DSD-related genes, such as MAP3K4 and EMX2. Therefore, these molecular changes likely contribute to the undervirilized genitalia and mixed gonadal differentiation observed in the patient.
Identifying the PBX1 variant 46,XY DSD helps clinicians better understand the molecular mechanisms of sexual development. Although the role of PBX1 in the gonads was previously elusive, this case underscores its importance in differentiation. Consequently, genetic testing for PBX1 variants should be considered in syndromic DSD cases. Furthermore, early diagnosis through whole-exome sequencing allows for more personalized clinical management. This advancement ultimately improves our ability to counsel families regarding genetic risks and developmental outcomes in pediatric endocrinology.
The p.R237T variant reduces protein stability and prevents the PBX1 protein from moving into the cell nucleus. This prevents it from correctly regulating genes necessary for normal sexual development.
The patient presented with 46,XY DSD, characterized by severely undervirilized genitalia and gonadal dysgenesis featuring both ovarian and testicular differentiation.
PBX1 acts as a transcription factor expressed throughout embryonic stages. It plays a crucial role in organogenesis, and its variants are increasingly linked to diverse developmental conditions, including DSD.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional recommendation. Refer to the latest local and national guidelines for clinical practice.
References
Tsai MC et al. Functional validation of a novel PBX1 missense variant in a 46,XY girl. Sex Dev. 2026 Feb 26. doi: 10.1159/000550575. PMID: 41746858.
Ferraz-de-Souza B, et al. Transcription factors and the genetic control of sexual differentiation. Mol Cell Endocrinol. 2011.
Kopp MC, et al. PBX1 in human development and disease. Journal of Medical Genetics. 2021.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A novel PBX1 variant (p.R237T) is linked to 46,XY DSD, causing reduced protein stability and impaired nuclear translocation in gonadal differentiation....
6 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
